Skip to content

Sacrospinous fixation versus vaginal hysterectomy in treatment of uterine prolapse stage >= 2: a multi-center randomised controlled trial

Sacrospinous fixation versus vaginal hysterectomy in treatment of uterine prolapse stage >= 2: a multi-center randomised controlled trial - SSF versus vaginal hysterectomy in treatment of uterine prolapse stage >= 2

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON35140
Enrollment
198
Registered
2009-08-18
Start date
2009-11-06
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prolapse uterine descent

Interventions

Random allocation to sacrospinous fixation or vaginal hysterectomy

Sponsors

Isala Klinieken
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: POP-Q stage >=2 uterine descent requiring surgery. Patients with co-existing anterior/ posterior defects or concomitant incontinence surgery (TVT-O) can be included

Exclusion criteria

Exclusion criteria: - Previous pelvic floor or prolapse surgery - Known malignancy or abnormal cervical smears - Wish to preserve fertility - Unwilling to return for follow-up or language barriers - Presence of immunological / haematological disorders interfering with recovery after surgery - Abnormal ultrasound findings of uterus or ovaries, or abnormal uterine bleeding.

Design outcomes

Primary

MeasureTime frame
Primary outcome: anatomical outcome and recurrence rate assessed by a POP-Q-test.

Secondary

MeasureTime frame
Secondary outcomes are subjective improvement on urogenital symptoms and quality of life (assessed by disease-specific and quality of life questionnaires), complications following surgery, hospital stay, post-operative recovery, sexual functioning and costs.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)